SCHEMBL9277487

SCHEMBL9277487

CC(C)On1cc2ccccc2c1

nearest known ligand 0.33

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2A6 P11509 1/20 0.32
ALOX12 P18054 1/20 0.32
TLR8 Q9NR97 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.31
MAPT P10636 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.30
UGT2B7 P16662 1/20 0.30
KDM4E B2RXH2 2/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4914067 0.70
SCHEMBL4912130 0.64
Naphthalene SCHEMBL10892164 0.64 CYP2A6 (0.47) CYP1A2ALDH1A1CYP2A6ALOX12TLR8
SCHEMBL23860138 0.63 CYP1A2 (0.40) CYP1A2ALDH1A1MAPTKDM4ELMNA
SCHEMBL129937 0.62 CYP2A6 (0.44) ALDH1A1CYP2A6ALOX12MAPTKDM4E
Naphthalene SCHEMBL28460931 0.58 CYP2A6 (0.57) CYP1A2ALDH1A1CYP2A6ALOX12UGT2B7
Naphthalene SCHEMBL28234791 0.58 CYP2A6 (0.57) ALDH1A1CYP2A6ALOX12UGT2B7KDM4E
Naphthalene SCHEMBL8038891 0.58 CYP2A6 (0.57) CYP1A2ALDH1A1CYP2A6ALOX12UGT2B7
Naphthalene SCHEMBL10612593 0.58 CYP2A6 (0.57) CYP1A2ALDH1A1CYP2A6ALOX12MAPT
Naphthalene SCHEMBL329435 0.58 CYP2A6 (0.89) CYP1A2ALDH1A1CYP2A6ALOX12MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855438-A2 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES Galleon Pharmaceuticals, Inc. (US) 2015-04-08 EP disclosed
WO-2013181217-A2 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES GALLEON PHARMACEUTICALS, INC. (US) 2013-12-05 WO disclosed
EP-2646423-A1 NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES Galleon Pharmaceuticals, Inc. (US) 2013-10-09 EP disclosed
WO-2012074999-A1 NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES GALLEON PHARMACEUTICALS, INC. (US) 2012-06-07 WO disclosed